CymaBay Therapeutics, Inc.

TWO SIGMA ADVISERS, LP

Report date

12/31/2023

Quarter

2023 Q4

Filed

2/14/2024

Shares

120,200

Value ($000)

2,839

Weight

0.0%

2019 Q4 - 2023 Q4 (17 filings)

Shares History

History scope: non-option holdings only (PUT/CALL rows excluded).

All 13F Holders	Filing date	Value ($000s)	% of Holdings	Shares	Reporting period
2023 Q4	2/14/2024	2,839	0.0%	120,200	12/31/2023
2023 Q3	11/14/2023	9,960	0.0%	668,038	9/30/2023
2023 Q2	8/14/2023	12,663	0.0%	1,156,438	6/30/2023
2023 Q1	5/15/2023	12,337	0.0%	1,414,838	3/31/2023
2022 Q4	2/14/2023	2,530	0.0%	403,538	12/31/2022
2022 Q3	11/14/2022	1,329	0.0%	379,838	9/30/2022
2022 Q2	8/15/2022	435	0.0%	147,538	6/30/2022
2022 Q1	5/16/2022	395	0.0%	127,038	3/31/2022
2021 Q4	2/14/2022	633	0.0%	187,138	12/31/2021
2021 Q3	11/15/2021	1,401	0.0%	383,738	9/30/2021
2021 Q2	8/16/2021	3,699	0.0%	848,338	6/30/2021
2021 Q1	5/17/2021	5,983	0.0%	1,317,938	3/31/2021
2020 Q4	2/16/2021	6,977	0.0%	1,215,438	12/31/2020
2020 Q3	11/16/2020	2,955	0.0%	408,138	9/30/2020
2020 Q2	9/15/2020	1,301	0.0%	372,638	6/30/2020
2020 Q1	5/15/2020	521	0.0%	352,238	3/31/2020
2019 Q4	2/14/2020	238	0.0%	121,238	12/31/2019